SCHEMBL19824318

SCHEMBL19824318

CC1(C)c2ccccc2-c2ccc3oc4ccc(-c5cccc(-c6nc(-c7ccccc7)nc(-c7cccc8ccccc78)n6)c5)cc4c3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.36
MAPT P10636 6/20 0.36
HPGD P15428 5/20 0.36
HSD17B10 Q99714 5/20 0.36
KDM4E B2RXH2 5/20 0.36
MAPK1 P28482 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
TP53 P04637 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
PLA2G10 O15496 1/20 0.33
S1PR1 P21453 1/20 0.31
S1PR3 Q99500 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19131192 0.94 PLA2G2A (0.34) ALDH1A1MAPTHPGDSMN1; SMN2L3MBTL1
SCHEMBL19824317 0.92 PLA2G2A (0.35) ALDH1A1HPGDTSHRL3MBTL1PLA2G2A
SCHEMBL19196073 0.92 L3MBTL1 (0.36) SMN1; SMN2L3MBTL1PLA2G2APLA2G4APLA2G10
SCHEMBL19131658 0.91 ALDH1A1 (0.35) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL19132436 0.89 CHRNA1 (0.35) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL19802570 0.87 KDM4E (0.33) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL19131191 0.86 ENPP3 (0.34) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL22243909 0.86 PLA2G2A (0.34) ALDH1A1MAPTHPGDHSD17B10KDM4E
SCHEMBL22876458 0.86 PLA2G2A (0.34) SMN1; SMN2L3MBTL1PLA2G2APLA2G4APLA2G10
SCHEMBL19132325 0.85 GAA (0.34) SMN1; SMN2L3MBTL1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10957865-B2 Organic light emitting compound and organic light emitting diode including the same SFC CO., LTD. (KR) 2021-03-23 US disclosed
US-20210057655-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME SFC CO., LTD. (KR) 2021-02-25 US disclosed
EP-3275970-B1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME SFC CO LTD (KR) 2019-05-22 EP disclosed
US-20180040834-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME SFC CO., LTD. (KR) 2018-02-08 US disclosed
US-20180040834-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME SFC CO., LTD. (KR) 2018-02-08 US disclosed
EP-3275970-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME SFC Co., Ltd. (KR) 2018-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180040834-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME HARS1, ALDH1A2, ALDH1A1 ALDH1A1 3/4885MAPT 2672/4885HPGD 2065/4885
US-20210057655-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME HARS1, ALDH1A2, ALDH1A1 ALDH1A1 3/4885MAPT 2672/4885HPGD 2065/4885
US-10957865-B2 Organic light emitting compound and organic light emitting diode including the same HARS1, ALDH1A2, ALDH1A1 ALDH1A1 3/4885MAPT 2735/4885HPGD 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.